| Year |
Citation |
Score |
| 2016 |
Pickard AS, Jiang R, Lin HW, Rosenbloom S, Cella D. Using Patient-Reported Outcomes to Compare Relative Burden of Cancer: EQ-5D and Functional Assessment of Cancer Therapy-General in Eleven Types of Cancer. Clinical Therapeutics. PMID 27041407 DOI: 10.1016/J.Clinthera.2016.03.009 |
0.514 |
|
| 2014 |
Cella D, Choi S, Garcia S, Cook KF, Rosenbloom S, Lai JS, Tatum DS, Gershon R. Setting standards for severity of common symptoms in oncology using the PROMIS item banks and expert judgment. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 23: 2651-61. PMID 24938431 DOI: 10.1007/S11136-014-0732-6 |
0.433 |
|
| 2012 |
Butt Z, Parikh ND, Beaumont JL, Rosenbloom SK, Syrjala KL, Abernethy AP, Benson AB, Cella D. Development and validation of a symptom index for advanced hepatobiliary and pancreatic cancers: the National Comprehensive Cancer Network Functional Assessment of Cancer Therapy (NCCN-FACT) Hepatobiliary-Pancreatic Symptom Index (NFHSI). Cancer. 118: 5997-6004. PMID 22605658 DOI: 10.1002/Cncr.27588 |
0.551 |
|
| 2012 |
Garcia SF, Rosenbloom SK, Beaumont JL, Merkel D, Von Roenn JH, Rao D, Cella D. Priority symptoms in advanced breast cancer: development and initial validation of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16). Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 15: 183-90. PMID 22264987 DOI: 10.1016/J.Jval.2011.08.1739 |
0.535 |
|
| 2012 |
Yount S, Beaumont J, Rosenbloom S, Cella D, Patel J, Hensing T, Jacobsen PB, Syrjala K, Abernethy AP. A brief symptom index for advanced lung cancer Clinical Lung Cancer. 13: 14-23. PMID 21729652 DOI: 10.1016/J.Cllc.2011.03.033 |
0.532 |
|
| 2012 |
Lai JS, Garcia SF, Salsman JM, Rosenbloom S, Cella D. The psychosocial impact of cancer: evidence in support of independent general positive and negative components. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 21: 195-207. PMID 21643875 DOI: 10.1007/S11136-011-9935-2 |
0.364 |
|
| 2012 |
Butt Z, Parikh ND, Beaumont JL, Rosenbloom S, Cella D. 459 Development and Validation of a Symptom Index for Advanced Hepatobiliary Cancers: the NCCN-FACT Hepatobiliary Symptom Index Gastroenterology. 142. DOI: 10.1016/S0016-5085(12)63550-1 |
0.501 |
|
| 2011 |
Cella D, Rosenbloom SK, Beaumont JL, Yount SE, Paul D, Hampton D, Abernethy AP, Jacobsen PB, Syrjala K, Von Roenn JH. Development and validation of 11 symptom indexes to evaluate response to chemotherapy for advanced cancer. Journal of the National Comprehensive Cancer Network : Jnccn. 9: 268-78. PMID 21393439 DOI: 10.6004/Jnccn.2011.0026 |
0.564 |
|
| 2011 |
Jensen SE, Rosenbloom SK, Beaumont JL, Abernethy A, Jacobsen PB, Syrjala K, Cella D. A new index of priority symptoms in advanced ovarian cancer. Gynecologic Oncology. 120: 214-9. PMID 21075440 DOI: 10.1016/J.Ygyno.2010.09.025 |
0.524 |
|
| 2011 |
Victorson DE, Beaumont JL, Rosenbloom SK, Shevrin D, Cella D. Efficient assessment of the most important symptoms in advanced prostate cancer: the NCCN/FACT-P Symptom Index. Psycho-Oncology. 20: 977-83. PMID 20661866 DOI: 10.1002/Pon.1817 |
0.483 |
|
| 2010 |
Butt Z, Rao AV, Lai JS, Abernethy AP, Rosenbloom SK, Cella D. Age-associated differences in fatigue among patients with cancer. Journal of Pain and Symptom Management. 40: 217-23. PMID 20541901 DOI: 10.1016/J.Jpainsymman.2009.12.016 |
0.448 |
|
| 2009 |
Rao D, Butt Z, Rosenbloom S, Robinson D, Von Roenn J, Kuzel TM, Cella D. A Comparison of the Renal Cell Carcinoma-Symptom Index (RCC-SI) and the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI) Journal of Pain and Symptom Management. 38: 291-298. PMID 19356897 DOI: 10.1016/J.Jpainsymman.2008.08.013 |
0.482 |
|
| 2008 |
Butt Z, Rosenbloom SK, Abernethy AP, Beaumont JL, Paul D, Hampton D, Jacobsen PB, Syrjala KL, Von Roenn JH, Cella D. Fatigue is the most important symptom for advanced cancer patients who have had chemotherapy. Journal of the National Comprehensive Cancer Network : Jnccn. 6: 448-55. PMID 18492460 DOI: 10.6004/Jnccn.2008.0036 |
0.549 |
|
| 2007 |
Nieman CL, Kinahan KE, Yount SE, Rosenbloom SK, Yost KJ, Hahn EA, Volpe T, Dilley KJ, Zoloth L, Woodruff TK. Fertility preservation and adolescent cancer patients: lessons from adult survivors of childhood cancer and their parents. Cancer Treatment and Research. 138: 201-17. PMID 18080667 DOI: 10.1007/978-0-387-72293-1_15 |
0.439 |
|
| 2007 |
Rosenbloom SK, Victorson DE, Hahn EA, Peterman AH, Cella D. Assessment is not enough: a randomized controlled trial of the effects of HRQL assessment on quality of life and satisfaction in oncology clinical practice. Psycho-Oncology. 16: 1069-79. PMID 17342789 DOI: 10.1002/Pon.1184 |
0.386 |
|
| 2007 |
Pickard AS, Leon MCD, Kohlmann T, Cella D, Rosenbloom S. Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Medical Care. 45: 259-263. PMID 17304084 DOI: 10.1097/01.Mlr.0000254515.63841.81 |
0.3 |
|
| 2007 |
Rosenbloom SK, Beaumont J, Diaz P, Yount SE, Abernethy AP, Jacobsen PB, Paul D, Syrjala K, Roenn JHV, Cella D. Patient-centered validation of 11 symptom indices to evaluate response to chemotherapy for advanced cancer Journal of Clinical Oncology. 25: 6524-6524. DOI: 10.1200/Jco.2007.25.18_Suppl.6524 |
0.485 |
|
| 2007 |
Pickard A, Lin H, Leon MD, Rosenbloom S, Cella D. Pcn52 Comparison Of Impact Of Eleven Types Of Advanced Cancer On Quality Of Life Value in Health. 10. DOI: 10.1016/S1098-3015(10)68962-0 |
0.409 |
|
| 2003 |
Gershon R, Cella D, Dineen K, Rosenbloom S, Peterman A, Lai J. Item response theory and health-related quality of life in cancer. Expert Review of Pharmacoeconomics & Outcomes Research. 3: 783-791. PMID 19807355 DOI: 10.1586/14737167.3.6.783 |
0.393 |
|
| Show low-probability matches. |